Two 6-Minute Walk Tests Recommended for Suspected Pulmonary Hypertension
In the initial assessment, more than half of the study participants were able to walk farther in the second 6MWT than in the first.
In untreated patients with pulmonary arterial hypertension and in controls, the fluctuations in systolic pulmonary artery pressure (PAP) and diastolic PAP around mean PAP exhibited constant scaling factor shown to ...
LIQ861, an inhaled dry powder formulation of treprostinil, was well tolerated in patients with pulmonary arterial hypertension at a 2-week time point in the phase 3 clinical trial, INSPIRE.
Elevated levels of myocardial native T1 are associated with increased interventricular septal angle in patients with pulmonary hypertension.